These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 18492530

  • 21. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.
    Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR.
    Lancet; 2007 Apr 07; 369(9568):1179-86. PubMed ID: 17416262
    [Abstract] [Full Text] [Related]

  • 22. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
    Simberkoff MS.
    Semin Respir Infect; 1993 Dec 07; 8(4):294-9. PubMed ID: 7938926
    [Abstract] [Full Text] [Related]

  • 23. [Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France].
    Bekri H, Cohen R, Varon E, Madhi F, Gire R, Guillot F, Delacourt C.
    Arch Pediatr; 2007 Mar 07; 14(3):239-43. PubMed ID: 17276044
    [Abstract] [Full Text] [Related]

  • 24. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay.
    Pírez MC, Algorta G, Cedrés A, Sobrero H, Varela A, Giachetto G, Montano A.
    Pediatr Infect Dis J; 2011 Aug 07; 30(8):669-74. PubMed ID: 21407145
    [Abstract] [Full Text] [Related]

  • 25. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.
    Madhi SA, Kuwanda L, Cutland C, Klugman KP.
    Clin Infect Dis; 2005 May 15; 40(10):1511-8. PubMed ID: 15844075
    [Abstract] [Full Text] [Related]

  • 26. A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age.
    Hortal M, Estevan M, Iraola I, De Mucio B.
    Int J Infect Dis; 2007 May 15; 11(3):273-7. PubMed ID: 16997592
    [Abstract] [Full Text] [Related]

  • 27. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F, Horcajada I, Cañas AM, Alamo I, Bordes A, González A, Santana M, Lafarga B.
    Enferm Infecc Microbiol Clin; 2009 Jan 15; 27(1):14-21. PubMed ID: 19217998
    [Abstract] [Full Text] [Related]

  • 28. Clinical and microbiological aspects of acute community-acquired pneumonia due to Streptococcus pneumoniae.
    Cardinal-Fernández P, García Gabarrot G, Echeverria P, Zum G, Hurtado J, Rieppi G.
    Rev Clin Esp (Barc); 2013 Mar 15; 213(2):88-96. PubMed ID: 23178082
    [Abstract] [Full Text] [Related]

  • 29. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R.
    Pediatr Infect Dis J; 2009 Apr 15; 28(4):277-82. PubMed ID: 19258924
    [Abstract] [Full Text] [Related]

  • 30. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.
    Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H, ARIVAC Consortium.
    Vaccine; 2009 May 05; 27(20):2680-8. PubMed ID: 19428879
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Parapneumonic pleural effusion incidence in a French region before and during the antipneumococcal vaccine era].
    Masson A, Ménetrey C, Garnier F, Bahans C, Fargeot A, Layadi M, Soulier JL, Guigonis V.
    Arch Pediatr; 2011 Aug 05; 18(8):846-9. PubMed ID: 21664805
    [Abstract] [Full Text] [Related]

  • 36. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features.
    Ortqvist A, Hedlund J, Kalin M.
    Semin Respir Crit Care Med; 2005 Dec 05; 26(6):563-74. PubMed ID: 16388428
    [Abstract] [Full Text] [Related]

  • 37. [Study of hospitalizations for pneumococcal pneumoniae in Centre region, 2004-2008].
    Grammatico-Guillon L, Thiercelin N, Mariani S, Lecuyer AI, Goudeau A, Bernard L, Rusch E.
    Rev Epidemiol Sante Publique; 2012 Feb 05; 60(1):1-8. PubMed ID: 22245493
    [Abstract] [Full Text] [Related]

  • 38. Nasopharyngeal carriage of Streptococcus pneumoniae in Navajo and White Mountain Apache children before the introduction of pneumococcal conjugate vaccine.
    Millar EV, O'Brien KL, Zell ER, Bronsdon MA, Reid R, Santosham M.
    Pediatr Infect Dis J; 2009 Aug 05; 28(8):711-6. PubMed ID: 19593248
    [Abstract] [Full Text] [Related]

  • 39. Penicillin resistance and serotyping of Streptococcus pneumoniae in Latin America.
    Camargos P, Fischer GB, Mocelin H, Dias C, Ruvinsky R.
    Paediatr Respir Rev; 2006 Sep 05; 7(3):209-14. PubMed ID: 16938644
    [Abstract] [Full Text] [Related]

  • 40. Invasive pneumococcal disease in Singapore children.
    Chong CY, Koh-Cheng T, Yee-Hui M, Nancy TW.
    Vaccine; 2008 Jun 25; 26(27-28):3427-31. PubMed ID: 18499309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.